Acorda Therapeutics Adds Lorin J. Randall To Board Of Directors

HAWTHORNE, N.Y.--(BUSINESS WIRE)--March 10, 2006--Acorda Therapeutics (Nasdaq: ACOR) has announced that Lorin J. Randall, Senior Vice President and Chief Financial Officer for Eximias Pharmaceutical Corporation, has become a member of the Acorda Board of Directors and will serve as the Chairman of Acorda's Audit Committee.

Back to news